The Expression of Multiple Proteins as Prognostic Factors in Colorectal Cancer: Cathepsin D, p53, COX-2, Epidermal Growth Factor Receptor, C-erbB-2, and Ki-67
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: A single gene mutation alone cannot explain the poor prognosis of colorectal cancer. This study aimed to establish a correlation between the expression of six proteins and the prognosis of colorectal cancer patients. Methods: Tissue samples were collected from 266 patients who underwent surgery for colorectal cancer at our institution from January 2006 to December 2007. The expression of six proteins were determined using immunohistochemical staining of specimens. Results: Cathepsin D, p53, COX-2, epidermal growth factor receptor, c-erbB-2, and Ki-67 expression were detected in 38.7%, 60.9%, 37.6%, 35.7%, 30.1%, and 74.4% of the samples, respectively. The expression of cathepsin D was significantly correlated with reduced cancer-free survival (p=0.036) and colorectal cancer-specific survival (p=0.003), but the other expression levels were not. In a multivariate analysis, cathepsin D expression was found to be an independent prognostic factor for poorer colorectal cancer-specific survival (hazard ratio, 8.55; 95% confidence interval, 1.07 to 68.49). Furthermore, patients with tumors expressing four or more of the proteins had a significantly decreased cancer-free survival rate (p=0.006) and colorectal cancer-specific survival rate (p=0.002). Conclusions: Patients with cathepsin D positivity had a poorer outcome than patients who were cathepsin D-negative. Thus, cathepsin D may provide an indicator for appropriate intensive follow-up and adjuvant chemotherapy.
Abstract
Background/Aims: A single gene mutation alone cannot explain the poor prognosis of colorectal cancer. This study aimed to establish a correlation between the expression of six proteins and the prognosis of colorectal cancer patients. Methods: Tissue samples were collected from 266 patients who underwent surgery for colorectal cancer at our institution from January 2006 to December 2007. The expression of six proteins were determined using immunohistochemical staining of specimens. Results: Cathepsin D, p53, COX-2, epidermal growth factor receptor, c-erbB-2, and Ki-67 expression were detected in 38.7%, 60.9%, 37.6%, 35.7%, 30.1%, and 74.4% of the samples, respectively. The expression of cathepsin D was significantly correlated with reduced cancer-free survival (p=0.036) and colorectal cancer-specific survival (p=0.003), but the other expression levels were not. In a multivariate analysis, cathepsin D expression was found to be an independent prognostic factor for poorer colorectal cancer-specific survival (hazard ratio, 8.55; 95% confidence interval, 1.07 to 68.49). Furthermore, patients with tumors expressing four or more of the proteins had a significantly decreased cancer-free survival rate (p=0.006) and colorectal cancer-specific survival rate (p=0.002). Conclusions: Patients with cathepsin D positivity had a poorer outcome than patients who were cathepsin D-negative. Thus, cathepsin D may provide an indicator for appropriate intensive follow-up and adjuvant chemotherapy.
참고문헌 (39)
- Huh JW, "Expression of p16, p53, and Ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases", Hepatogastroenterology, 57, pp.734~740 (2010)
- Sheehan KM, "The relationship between cyclooxygenase-2 expression and colorectal cancer", JAMA, 282, pp.1254~1257 (1999)
- Hanahan D, "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)
- Rajagopalan H, "The significance of unstable chromosomes in colorectal cancer", Nat Rev Cancer, 3, pp.695~701 (2003)
- Theodoropoulos GE, "Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma", J Surg Oncol, 65, pp.242~248 (1997)
- Nasir A, "Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy", Clin Colorectal Cancer, 3, pp.243~247 (2004)
- Kountourakis P, "Clinicopathologic significance of EGFR and Her-2", neu in colorectal adenocarcinomas, 2006, pp.12, 229~236
- Mayer A, "Immunohistochemical evaluation of cathepsin D expression in colorectal cancer", Cancer Invest, 15, pp.106~110 (1997)
- Tejpar S, "Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery", Oncologist, 15, pp.390~404 (2010)
- Tomozawa S, "Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer", Br J Cancer, 83, pp.324~328 (2000)
- Yamauchi T, "Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer", Dis Colon Rectum, 45, pp.98~103 (2002)
- Saftig P, "Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells", EMBO J, 14, pp.3599~3608 (1995)
- Sis B, "Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma", Pathol Res Pract, 200, pp.379~387 (2004)
- Talieri M, "Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma", Cancer Lett, 205, pp.97~106 (2004)
- Kirana C, "Cathepsin D expression in colorectal cancer: from proteomic discovery through validation using Western blotting, immunohistochemistry, and tissue microarrays", Int J Proteomics, 2012, pp.245819~ (2012)
- Baker SJ, "p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis", Cancer Res, 50, pp.7717~7722 (1990)
- Belluco C, "p53 nuclear protein overexpression in colorectal cancer : a dominant predictor of survival in patients with advanced hepatic metastases", J Clin Oncol 1996;, 14, pp.2696~2701 (1996)
- Yamaguchi A, "Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis", Cancer, 70, pp.2778~2784 (1992)
- Lan YT, "p53 protein accumulation as a prognostic marker in sporadic colorectal cancer", Int J Colorectal Dis, 22, pp.499~506 (2007)
- Soong R, "p53 alterations are associated with improved prognosis in distal colonic carcinomas", Clin Cancer Res, 3, pp.1405~1411 (1997)
- Nathanson SD, "Relationship among p53, stage, and prognosis of large bowel cancer", Dis Colon Rectum, 37, pp.527~534 (1994)
- Smith DR, "Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas", Br J Cancer, 74, pp.216~223 (1996)
- Tsujii M, "Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2", Cell, 83, pp.493~501 (1995)
- Thun MJ, "Aspirin use and reduced risk of fatal colon cancer", N Engl J Med, 325, pp.1593~1596 (1991)
- Soumaoro LT, "Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer", Clin Cancer Res, 10, pp.8465~8471 (2004)
- Fux R, "Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival", Clin Cancer Res, 11, pp.4754~4760 (2005)
- Bubendorf L, "Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectom", J Pathol, 178, pp.437~441 (1996)
- Jansen RL, "MIB-1 labelling index is an independent prognostic marker in primary breast cancer", Br J Cancer, 78, pp.460~465 (1998)
- Chen YT, "Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index", J Gastrointest Surg, 1, pp.266~272 (1997)
- Allegra CJ, "Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study", J Clin Oncol, 21, pp.241~250 (2003)
- Tabernero J, "Multigene assays to improve assessment of recurrence risk and benefit from chemotherapy in early-stage colon cancer: has the time finally arrived, or are we still stage locked?", J Clin Oncol, 28, pp.3904~3907 (2010)
- Schena M, "Quantitative monitoring of gene expression patterns with a complementary DNA microarray", Science, 270, pp.467~470 (1995)
- Perou CM, "Molecular portraits of human breast tumours", Nature, 406, pp.747~752 (2000)
- van de Vijver MJ, "A gene-expression signature as a predictor of survival in breast cancer", N Engl J Med, 347, pp.1999~2009 (2002)
- van’t Veer LJ, "Gene expression profiling predicts clinical outcome of breast cancer", Nature, 415, pp.530~536 (2002)
- Bertucci F, "Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters", Oncogene, 23, pp.1377~1391 (2004)
- Eschrich S, "Molecular staging for survival prediction of colorectal cancer patients", J Clin Oncol, 23, pp.3526~3535 (2005)
- Kavanagh DO, "Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?", BMC Cancer, 9, pp.1~ (2009)
- McKay JA, "Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases", Eur J Cancer, 38, pp.2258~2264 (2002)
